FDA Drugs (New Approvals & NDA)Original article
Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
RegulatoryBrevital® Sodium 500 mg/vial CIVNegative
AI Analysis
Summary
Par Health voluntarily recalled two lots of Brevital® Sodium 500 mg/vial due to the presence of cellulose particulate matter. The recall affects hospital-level distribution.
Outcome Details
Voluntary recall of two lots due to presence of particulate matter (cellulose)
Importance:4/10
Sentiment:
-0.70
product recallsafetyparticulate mattermanufacturinghospital level
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 9, 2026 3:22 PM